Cogent Biosciences, Inc. (COGT) Dividend History

Company News

• Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock

  Cogent Biosciences plans to raise approximately $200 million through a public offering of 22,222,223 common stock shares at $9.00 per share, with proceeds intended for product development and corporate purposes.

  GlobeNewswire Inc.
• Cogent (COGT) Up on SUMMIT Study Update Post Positive FDA Meeting

  Cogent (COGT) announces a positive FDA meeting and alignment on MS2D2, a novel patient-reported outcome measure for the SUMMIT study. The company's shares rise on the news.

  Zacks Investment Research

  Featured Companies: ALXO ANVS CGEN
• Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session

  U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday. Shares of Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) fell sharply in today’s pre-market trading after the company issued an update on the Phase 3 RAISE Trial and reported preliminary first quarter 2024 financial results. Marinus Pharma reported Prelim ZTALMY (Ganaxolone) net product revenue of $7.4 million to $7.6 million for the first quarter. Marinus Pharmaceuticals shares dipped 74.2% to $1.94in pre-market trading. Here are ...

  Benzinga

  Featured Companies: MOH NMRA PSNY RARE RDZN TRMD